Investigation of Novel Functions of KICSTOR Components in the DNA Damage Response

Manideep Chowdary Pachva; Alexander Ryan

doi:doi:10.11648/j.jcebe.20180202.14

| Peer-Reviewed

Investigation of Novel Functions of KICSTOR Components in the DNA Damage Response

Manideep Chowdary Pachva, Alexander Ryan

Published in Journal of Chemical, Environmental and Biological Engineering (Volume 2, Issue 2)

Received: 7 October 2018 Accepted: 10 November 2018 Published: 26 December 2018

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

The mechanistic target of rapamycin complex (mTOR) is an atypical serine/threonine kinase which acts as a global cellular regulator of growth and cell survival in response to environmental cues and is a member of the phosphoinositide 3-kinase (PI3K)-related kinase family. Through the numerous inhibitions and initiations of catabolic and anabolic processes respectively, mTORC1 is also a major promoter for cell-cycle progression. mTORC1 can be activated by growth factors such as insulin as a downstream target of PI3K signaling. It is expressed in all somatic cell types plays vital roles in axonal movement, neuronal plasticity and development in the brain. The aberrant activation of mTORC1 has been implicated as one of the leading causes of Tuberous Sclerosis and Focal Epilepsies. Constitutively active mutations in mTOR complex subunits and their upstream signalling proteins have also been documented in over 30% of Cancers, such as the recently recognised links to prostate and colon cancer. Some PI3K/mTOR inhibitors have also been shown to potently inhibit DNA damage responses in non-small cell lung cancer (NSCLC) cell lines suggesting mTOR plays a key role in DNA damage response (DDR) mechanisms. This review focuses on delineating the mTOR pathway, mechanism of mTOR inhibitors and their possible role in inhibiting the DDR mechanism.

Published in	Journal of Chemical, Environmental and Biological Engineering (Volume 2, Issue 2)
DOI	10.11648/j.jcebe.20180202.14
Page(s)	60-69
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2018. Published by Science Publishing Group

Keywords

mTOR, Cancer, DDR, KICSTOR

References

[1]	Hanahan, D. & Weinberg, R. A. 2011. Hallmarks of cancer: the next generation. Cell. 144 (5). pp. 646-674.
[2]	Cheng, N., Chytil, A., Shyr, Y., Joly, A. & Moses, H. L. 2008. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promotescattering and invasion. Molecular cancer research: MCR. 6 (10). pp. 1521-1533.
[3]	O'Reilly, K. E., Rojo, F., She, Q. B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., Baselga, J. & Rosen, N. 2006. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer research. 66 (3). pp. 1500-1508.
[4]	Torgovnick, A. & Schumacher, B. 2015. DNA repair mechanisms in cancer development and therapy. Frontiers in genetics. 6 pp. 157.
[5]	DeBont, R. & van Larebeke, N. 2004. Endogenous DNA damage in humans: a review of quantitative data. Mutagenesis. 19 (3). pp. 169-185.
[6]	Lindahl, T. & Barnes, D. E. 2000. Repair of endogenous DNA damage. Cold Spring Harbor symposia on quantitative biology. 65 pp. 127-133.
[7]	West, S. C. 2003. Molecular views of recombination proteins and their control. Nature reviews Molecular cell biology. 4 (6). pp. 435-445.
[8]	Ciccia, A. & Elledge, S. J. 2010. The DNA damage response: making it safe to play with knives. Molecular cell. 40 (2). pp. 179-204.
[9]	Guo, F. 2014. Mtor-Fanconi Anemia DNA Damage Repair Pathway in Cancer. Journal of oncobiomarkers. 2 (2). pp. 5.
[10]	Hoeijmakers, J. H. 2009. DNA damage, aging, and cancer. New England Journal of Medicine. 361 (15). pp. 1475-1485.
[11]	Caldecott, K. W. 2008. Single-strand break repair and genetic disease. Nature Reviews Genetics. 9 (8). pp. 619-631.
[12]	Kuo, L. J. & Yang, L. X. 2008. Gamma-H2AX - a novel biomarker for DNA double-strand breaks. In vivo (Athens, Greece). 22 (3). pp. 305-309.
[13]	Meek, K., Dang, V. & Lees-Miller, S. P. 2008. DNA-PK: the means to justify the ends? Advances in Immunology. 99 pp. 33-58.
[14]	Shrivastav, M., De Haro, L. P. & Nickoloff, J. A. 2008. Regulation of DNA double-strand break repair pathway choice. Cell research. 18 (1). pp. 134-147.
[15]	Jeggo, P. A. & Lobrich, M. 2005. Artemis links ATM to double strand break rejoining. Cell cycle. 4 (3). pp. 359-362.
[16]	Laplante, M. & Sabatini, D. M. 2012. mTOR signaling in growth control and disease. Cell. 149 (2). pp. 274-293.
[17]	Cafferkey, R., Young, P. R., McLaughlin, M. M., Bergsma, D. J., Koltin, Y., Sathe, G. M., Faucette, L., Eng, W. K., Johnson, R. K. & Livi, G. P. 1993. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3- kinase and VPS34 abrogate rapamycin cytotoxicity. Molecular and cellular biology. 13 (10). pp. 6012-6023.
[18]	Brown, E. J., Albers, M. W., Shin, T. B., Ichikawa, K., Keith, C. T., Lane, W. S. & Schreiber S. L. 1994. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature. 369 (6483). pp. 756.
[19]	Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S. H. 1994. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell. 78 (1). pp. 35-43.
[20]	Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht, G. & Abraham, R. T. 1995. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. Journal of Biological Chemistry. 270 (2). pp. 815- 822.
[21]	Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A. L., Nada, S. & Sabatini, D. M. 2010. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell. 141 (2). pp. 290-303.
[22]	Kim, D., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P. & Sabatini, D. M. 2002. mTOR interacts with raptor to form a nutrient- sensitive complex that signals to the cell growth machinery. Cell. 110 (2). pp. 163-175.
[23]	Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A. & Chen, J. 2001. Phosphatidic acid- mediated mitogenic activation of mTOR signaling. Science (New York, N. Y.). 294 (5548). pp. 1942-1945.
[24]	Yip, C. K., Murata, K., Walz, T., Sabatini, D. M. & Kang, S. A. 2010. Structure of the human mTOR complex I and its implications for rapamycin inhibition. Molecular cell. 38 (5). pp. 768-774.
[25]	Baldassari, S., Licchetta, L., Tinuper, P., Bisulli, F. & Pippucci, T. 2016. GATOR1 complex: the common genetic actor in focal epilepsies. Journalofmedical genetics. 53 (8). pp. 503-510.
[26]	Mao, Z., Bozzella, M., Seluanov, A. & Gorbunova, V. 2008. DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells. Cell cycle. 7 (18). pp. 2902-2906.
[27]	Shimobayashi, M. & Hall, M. N. 2016. Multiple amino acid sensing inputs to mTORC1. Cell research. 26 (1). pp. 7-20.
[28]	Durán, R. V., Oppliger, W., Robitaille, A. M., Heiserich, L., Skendaj, R., Gottlieb, E. & Hall, M. N. 2012. Glutaminolysis activates Rag-mTORC1 signaling. Molecular cell. 47 (3). pp. 349-358.
[29]	Bar-Peled, L., Chantranupong, L., Cherniack, A. D., Chen, W. W., Ottina, K. A., Grabiner, B. C., Spear, E. D., Carter, S. L., Meyerson, M. & Sabatini, D. M. 2013. A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science (New York, N. Y.). 340 (6136). pp. 1100-1106.
[30]	Miki, D., Ochi, H., Hayes, C. N., Abe, H., Yoshima, T., Aikata, H., Ikeda, K., Kumada, H., Toyota, J. & Morizono, T. 2011. Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers. Nature genetics. 43 (8). pp. 797-800.
[31]	Seng, T. J., Ichimura, K., Liu, L., Tingby, O., Pearson, D. M. & Collins, V. P. 2005. Complex chromosome 22 rearrangements in astrocytic tumors identified using microsatellite and chromosome 22 tile path array analysis. Genes, Chromosomes and Cancer. 43 (2). pp. 181-193.
[32]	Chantranupong, L., Wolfson, R. L., Orozco, J. M., Saxton, R. A., Scaria, S. M., Bar- Peled, L., Spooner, E., Isasa, M., Gygi, S. P. & Sabatini, D. M. 2014. The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1. Cell reports. 9 (1). pp. 1-8.
[33]	Wang, S., Tsun, Z. Y., Wolfson, R. L., Shen, K., Wyant, G. A., Plovanich, M. E., Yuan, E. D., Jones, T. D., Chantranupong, L., Comb, W., Wang, T., Bar-Peled, L., Zoncu, R., Straub, C., Kim, C., Park, J., Sabatini, B. L. & Sabatini, D. M. 2015. Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1. Science (New York, N. Y.). 347 (6218). pp. 188-194.
[34]	Wolfson, R. L., Chantranupong, L., Wyant, G. A., Gu, X., Orozco, J. M., Shen, K., Condon, K. J., Petri, S., Kedir, J. & Scaria, S. M. 2017. KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1. Nature. 543 (7645). pp. 438-442.
[35]	Peng, M., Yin, N. & Li, M. O. 2017. SZT2 dictates GATOR control of mTORC1 signalling. Nature.
[36]	Frankel, W. N., Yang, Y., Mahaffey, C. L., Beyer, B. J. & O'Brien, T. P. 2009. Szt2, a novel gene for seizure threshold in mice. Genes, Brain and Behavior. 8 (5). pp. 568-576.
[37]	Baple, E. L., Maroofian, R., Chioza, B. A., Izadi, M., Cross, H. E., Al-Turki, S., Barwick, K., Skrzypiec, A., Pawlak, R. & Wagner, K. 2014. Mutations in KPTN cause macrocephaly, neurodevelopmental delay, and seizures. The American Journal of Human Genetics. 94 (1). pp. 87-94.
[38]	Ma, X. M. & Blenis, J. 2009. Molecular mechanisms of mTOR-mediated translational control. Nature reviews Molecular cell biology. 10 (5). pp. 307-318.
[39]	Holler, M., Grottke, A., Mueck, K., Manes, J., Jücker, M., Rodemann, H. P. & Toulany, M. 2016. Dual Targeting of Akt and mTORC1 Impairs Repair of DNA Double- Strand Breaks and Increases Radiation Sensitivity of Human Tumor Cells. PloS one. 11 (5). pp. e0154745.
[40]	Mukherjee, B., Tomimatsu, N., Amancherla, K., Camacho, C. V., Pichamoorthy, N. & Burma, S. 2012. The dual PI3K/mTOR inhibitor NVP-BEZ235 is a potent inhibitor of ATM-and DNA-PKCs-mediated DNA damage responses. Neoplasia. 14 (1). pp. 34IN5-43IN8.
[41]	Dominick, G., Bowman, J., Li, X., Miller, R. A. & Garcia, G. G. 2017. mTOR regulates the expression of DNA damage response enzymes in long‐lived Snell dwarf, GHRKO, and PAPPA‐KO mice. Aging cell. 16 (1). pp. 52-60.
[42]	Belin, B. J., Lee, T. & Mullins, R. D. 2015. DNA damage induces nuclear actin filament assembly by Formin -2 and Spire-(1/2) that promotes efficient DNA repair. [corrected. eLife. 4 pp. e07735.
[43]	Fell, V. L. & Schild-Poulter, C. 2012. Ku regulates signaling to DNA damage response pathways through the Ku70 von Willebrand A domain. Molecular and cellular biology. 32 (1). pp. 76.

Cite This Article

Plain Text BibTeX RIS

APA Style

Manideep Chowdary Pachva, Alexander Ryan. (2018). Investigation of Novel Functions of KICSTOR Components in the DNA Damage Response. Journal of Chemical, Environmental and Biological Engineering, 2(2), 60-69. https://doi.org/10.11648/j.jcebe.20180202.14

Copy | Download

ACS Style

Manideep Chowdary Pachva; Alexander Ryan. Investigation of Novel Functions of KICSTOR Components in the DNA Damage Response. J. Chem. Environ. Biol. Eng. 2018, 2(2), 60-69. doi: 10.11648/j.jcebe.20180202.14

Copy | Download

AMA Style

Manideep Chowdary Pachva, Alexander Ryan. Investigation of Novel Functions of KICSTOR Components in the DNA Damage Response. J Chem Environ Biol Eng. 2018;2(2):60-69. doi: 10.11648/j.jcebe.20180202.14

Copy | Download

@article{10.11648/j.jcebe.20180202.14,
  author = {Manideep Chowdary Pachva and Alexander Ryan},
  title = {Investigation of Novel Functions of KICSTOR Components in the DNA Damage Response},
  journal = {Journal of Chemical, Environmental and Biological Engineering},
  volume = {2},
  number = {2},
  pages = {60-69},
  doi = {10.11648/j.jcebe.20180202.14},
  url = {https://doi.org/10.11648/j.jcebe.20180202.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jcebe.20180202.14},
  abstract = {The mechanistic target of rapamycin complex (mTOR) is an atypical serine/threonine kinase which acts as a global cellular regulator of growth and cell survival in response to environmental cues and is a member of the phosphoinositide 3-kinase (PI3K)-related kinase family. Through the numerous inhibitions and initiations of catabolic and anabolic processes respectively, mTORC1 is also a major promoter for cell-cycle progression. mTORC1 can be activated by growth factors such as insulin as a downstream target of PI3K signaling. It is expressed in all somatic cell types plays vital roles in axonal movement, neuronal plasticity and development in the brain. The aberrant activation of mTORC1 has been implicated as one of the leading causes of Tuberous Sclerosis and Focal Epilepsies. Constitutively active mutations in mTOR complex subunits and their upstream signalling proteins have also been documented in over 30% of Cancers, such as the recently recognised links to prostate and colon cancer. Some PI3K/mTOR inhibitors have also been shown to potently inhibit DNA damage responses in non-small cell lung cancer (NSCLC) cell lines suggesting mTOR plays a key role in DNA damage response (DDR) mechanisms. This review focuses on delineating the mTOR pathway, mechanism of mTOR inhibitors and their possible role in inhibiting the DDR mechanism.},
 year = {2018}
}

Copy | Download

TY  - JOUR
T1  - Investigation of Novel Functions of KICSTOR Components in the DNA Damage Response
AU  - Manideep Chowdary Pachva
AU  - Alexander Ryan
Y1  - 2018/12/26
PY  - 2018
N1  - https://doi.org/10.11648/j.jcebe.20180202.14
DO  - 10.11648/j.jcebe.20180202.14
T2  - Journal of Chemical, Environmental and Biological Engineering
JF  - Journal of Chemical, Environmental and Biological Engineering
JO  - Journal of Chemical, Environmental and Biological Engineering
SP  - 60
EP  - 69
PB  - Science Publishing Group
SN  - 2640-267X
UR  - https://doi.org/10.11648/j.jcebe.20180202.14
AB  - The mechanistic target of rapamycin complex (mTOR) is an atypical serine/threonine kinase which acts as a global cellular regulator of growth and cell survival in response to environmental cues and is a member of the phosphoinositide 3-kinase (PI3K)-related kinase family. Through the numerous inhibitions and initiations of catabolic and anabolic processes respectively, mTORC1 is also a major promoter for cell-cycle progression. mTORC1 can be activated by growth factors such as insulin as a downstream target of PI3K signaling. It is expressed in all somatic cell types plays vital roles in axonal movement, neuronal plasticity and development in the brain. The aberrant activation of mTORC1 has been implicated as one of the leading causes of Tuberous Sclerosis and Focal Epilepsies. Constitutively active mutations in mTOR complex subunits and their upstream signalling proteins have also been documented in over 30% of Cancers, such as the recently recognised links to prostate and colon cancer. Some PI3K/mTOR inhibitors have also been shown to potently inhibit DNA damage responses in non-small cell lung cancer (NSCLC) cell lines suggesting mTOR plays a key role in DNA damage response (DDR) mechanisms. This review focuses on delineating the mTOR pathway, mechanism of mTOR inhibitors and their possible role in inhibiting the DDR mechanism.
VL  - 2
IS  - 2
ER  -

Copy | Download

Author Information

Manideep Chowdary Pachva

Department of Molecular Genetics, Bangor University, Bangor, United Kingdom
Alexander Ryan

Department of Molecular Genetics, Bangor University, Bangor, United Kingdom

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Manideep Chowdary Pachva, Alexander Ryan. (2018). Investigation of Novel Functions of KICSTOR Components in the DNA Damage Response. Journal of Chemical, Environmental and Biological Engineering, 2(2), 60-69. https://doi.org/10.11648/j.jcebe.20180202.14

Copy | Download

ACS Style

Manideep Chowdary Pachva; Alexander Ryan. Investigation of Novel Functions of KICSTOR Components in the DNA Damage Response. J. Chem. Environ. Biol. Eng. 2018, 2(2), 60-69. doi: 10.11648/j.jcebe.20180202.14

Copy | Download

AMA Style

Manideep Chowdary Pachva, Alexander Ryan. Investigation of Novel Functions of KICSTOR Components in the DNA Damage Response. J Chem Environ Biol Eng. 2018;2(2):60-69. doi: 10.11648/j.jcebe.20180202.14

Copy | Download

@article{10.11648/j.jcebe.20180202.14,
  author = {Manideep Chowdary Pachva and Alexander Ryan},
  title = {Investigation of Novel Functions of KICSTOR Components in the DNA Damage Response},
  journal = {Journal of Chemical, Environmental and Biological Engineering},
  volume = {2},
  number = {2},
  pages = {60-69},
  doi = {10.11648/j.jcebe.20180202.14},
  url = {https://doi.org/10.11648/j.jcebe.20180202.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jcebe.20180202.14},
  abstract = {The mechanistic target of rapamycin complex (mTOR) is an atypical serine/threonine kinase which acts as a global cellular regulator of growth and cell survival in response to environmental cues and is a member of the phosphoinositide 3-kinase (PI3K)-related kinase family. Through the numerous inhibitions and initiations of catabolic and anabolic processes respectively, mTORC1 is also a major promoter for cell-cycle progression. mTORC1 can be activated by growth factors such as insulin as a downstream target of PI3K signaling. It is expressed in all somatic cell types plays vital roles in axonal movement, neuronal plasticity and development in the brain. The aberrant activation of mTORC1 has been implicated as one of the leading causes of Tuberous Sclerosis and Focal Epilepsies. Constitutively active mutations in mTOR complex subunits and their upstream signalling proteins have also been documented in over 30% of Cancers, such as the recently recognised links to prostate and colon cancer. Some PI3K/mTOR inhibitors have also been shown to potently inhibit DNA damage responses in non-small cell lung cancer (NSCLC) cell lines suggesting mTOR plays a key role in DNA damage response (DDR) mechanisms. This review focuses on delineating the mTOR pathway, mechanism of mTOR inhibitors and their possible role in inhibiting the DDR mechanism.},
 year = {2018}
}

Copy | Download

TY  - JOUR
T1  - Investigation of Novel Functions of KICSTOR Components in the DNA Damage Response
AU  - Manideep Chowdary Pachva
AU  - Alexander Ryan
Y1  - 2018/12/26
PY  - 2018
N1  - https://doi.org/10.11648/j.jcebe.20180202.14
DO  - 10.11648/j.jcebe.20180202.14
T2  - Journal of Chemical, Environmental and Biological Engineering
JF  - Journal of Chemical, Environmental and Biological Engineering
JO  - Journal of Chemical, Environmental and Biological Engineering
SP  - 60
EP  - 69
PB  - Science Publishing Group
SN  - 2640-267X
UR  - https://doi.org/10.11648/j.jcebe.20180202.14
AB  - The mechanistic target of rapamycin complex (mTOR) is an atypical serine/threonine kinase which acts as a global cellular regulator of growth and cell survival in response to environmental cues and is a member of the phosphoinositide 3-kinase (PI3K)-related kinase family. Through the numerous inhibitions and initiations of catabolic and anabolic processes respectively, mTORC1 is also a major promoter for cell-cycle progression. mTORC1 can be activated by growth factors such as insulin as a downstream target of PI3K signaling. It is expressed in all somatic cell types plays vital roles in axonal movement, neuronal plasticity and development in the brain. The aberrant activation of mTORC1 has been implicated as one of the leading causes of Tuberous Sclerosis and Focal Epilepsies. Constitutively active mutations in mTOR complex subunits and their upstream signalling proteins have also been documented in over 30% of Cancers, such as the recently recognised links to prostate and colon cancer. Some PI3K/mTOR inhibitors have also been shown to potently inhibit DNA damage responses in non-small cell lung cancer (NSCLC) cell lines suggesting mTOR plays a key role in DNA damage response (DDR) mechanisms. This review focuses on delineating the mTOR pathway, mechanism of mTOR inhibitors and their possible role in inhibiting the DDR mechanism.
VL  - 2
IS  - 2
ER  -

Copy | Download